These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


390 related items for PubMed ID: 15036250

  • 21. The hypothalamic-pituitary-adrenal (HPA) axis in habitual smokers.
    Rohleder N, Kirschbaum C.
    Int J Psychophysiol; 2006 Mar; 59(3):236-43. PubMed ID: 16325948
    [Abstract] [Full Text] [Related]

  • 22. The 1microg short Synacthen test in chronic fatigue syndrome.
    Hudson M, Cleare AJ.
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):625-30. PubMed ID: 10594524
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The role of hypocortisolism in chronic fatigue syndrome.
    Nijhof SL, Rutten JM, Uiterwaal CS, Bleijenberg G, Kimpen JL, Putte EM.
    Psychoneuroendocrinology; 2014 Apr; 42():199-206. PubMed ID: 24636516
    [Abstract] [Full Text] [Related]

  • 31. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats.
    Surapaneni DK, Adapa SR, Preeti K, Teja GR, Veeraragavan M, Krishnamurthy S.
    J Ethnopharmacol; 2012 Aug 30; 143(1):91-9. PubMed ID: 22771318
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW, Quitkin FM, McGrath PJ, Klein DF.
    J Affect Disord; 2005 Jun 30; 86(2-3):161-7. PubMed ID: 15935235
    [Abstract] [Full Text] [Related]

  • 36. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL, Liberzon I, Young EA, Khan S.
    Arch Gen Psychiatry; 2005 Jun 30; 62(6):668-75. PubMed ID: 15939844
    [Abstract] [Full Text] [Related]

  • 37. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders.
    Tak LM, Cleare AJ, Ormel J, Manoharan A, Kok IC, Wessely S, Rosmalen JG.
    Biol Psychol; 2011 May 30; 87(2):183-94. PubMed ID: 21315796
    [Abstract] [Full Text] [Related]

  • 38. Stress, hypothalamic-pituitary-adrenal axis and eating disorders.
    Lo Sauro C, Ravaldi C, Cabras PL, Faravelli C, Ricca V.
    Neuropsychobiology; 2008 May 30; 57(3):95-115. PubMed ID: 18552511
    [Abstract] [Full Text] [Related]

  • 39. HPA- and HPT-axis alterations in chronic posttraumatic stress disorder.
    Olff M, Güzelcan Y, de Vries GJ, Assies J, Gersons BP.
    Psychoneuroendocrinology; 2006 Nov 30; 31(10):1220-30. PubMed ID: 17081699
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 20.